Loss of Cytoplasmic CDK1 Predicts Poor Survival in Human Lung Cancer and Confers Chemotherapeutic Resistance

The dismal lethality of lung cancer is due to late stage at diagnosis and inherent therapeutic resistance. The incorporation of targeted therapies has modestly improved clinical outcomes, but the identification of new targets could further improve clinical outcomes by guiding stratification of poor-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Zhang, Chunyu, Elkahloun, Abdel G., Robertson, Matthew, Gills, Joell J., Tsurutani, Junji, Shih, Joanna H., Fukuoka, Junya, Hollander, M. Christine, Harris, Curtis C., Travis, William D., Jen, Jin, Dennis, Phillip A.
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2011
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3161069/
https://ncbi.nlm.nih.gov/pubmed/21887332
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0023849
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars